These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12732709)

  • 1. Meta-analysis of transarterial embolization in patients with unresectable hepatocellular carcinoma.
    Myers RP
    Radiology; 2003 May; 227(2):611-2; author reply 612-3. PubMed ID: 12732709
    [No Abstract]   [Full Text] [Related]  

  • 2. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.
    Cammà C; Schepis F; Orlando A; Albanese M; Shahied L; Trevisani F; Andreone P; Craxì A; Cottone M
    Radiology; 2002 Jul; 224(1):47-54. PubMed ID: 12091661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Daniels JR
    AJR Am J Roentgenol; 2011 Feb; 196(2):W220. PubMed ID: 21257869
    [No Abstract]   [Full Text] [Related]  

  • 5. Transarterial chemoembolization using doxorubicin beads for unresectable hepatocellular carcinoma.
    Poston GJ
    Onkologie; 2010; 33(1-2):5-6. PubMed ID: 20164653
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies.
    Tournoux C; Paoletti X; Barbare JC
    Cancer Treat Rev; 2007 Dec; 33(8):762-3. PubMed ID: 17643827
    [No Abstract]   [Full Text] [Related]  

  • 7. Unresectable hepatocellular carcinoma: meta-analysis of arterial embolization.
    Llovet JM; Bruix J
    Radiology; 2004 Jan; 230(1):300-1; author reply 301-2. PubMed ID: 14695404
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of preoperative transarterial chemoembolization on the prognosis for patients with resectable hepatocellular carcinoma: a meta-analysis of randomized trials.
    Wang X; Li J; Peng Y; Dai Y; Xu W
    Hepatogastroenterology; 2011; 58(107-108):869-74. PubMed ID: 21830407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization.
    Padhani A
    Radiology; 2009 Feb; 250(2):324-6. PubMed ID: 19188308
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
    Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C
    Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Meng MB; Wen QL; Cui YL; She B; Zhang RM
    Explore (NY); 2011; 7(1):37-43. PubMed ID: 21194671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter.
    Huang YH; Wu JC; Chen SC; Chen CH; Chiang JH; Huo TI; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2006 Jan; 23(1):129-35. PubMed ID: 16393290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.
    Georgiades CS; Hong K; D'Angelo M; Geschwind JF
    J Vasc Interv Radiol; 2005 Dec; 16(12):1653-9. PubMed ID: 16371532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
    Tsochatzis E; Meyer T; Marelli L; Burroughs AK
    J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
    [No Abstract]   [Full Text] [Related]  

  • 16. Bleeding gastric ulcer after prophylactic coiling of transarterial chemoembolization.
    Chang CJ; Hou MC; Tseng HS; Liao WC; Lin HC; Lee SD
    J Clin Gastroenterol; 2010 Sep; 44(8):588-91. PubMed ID: 20453659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma (Br J Surg 2003; 90: 325-331).
    Sen G; Rai R; Manas DM
    Br J Surg; 2003 Aug; 90(8):1022. PubMed ID: 12905563
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Tez M; Zulfikaroglu B
    Cancer; 2008 Jun; 112(12):2820-1; author reply 2821. PubMed ID: 18465802
    [No Abstract]   [Full Text] [Related]  

  • 19. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.
    Huang ZL; Luo J; Chen MS; Li JQ; Shi M
    J Vasc Interv Radiol; 2011 May; 22(5):702-9. PubMed ID: 21514523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.